1 Boise LH, "a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death" 74 : 597-608, 1993
2 Ansari L, "The most prevalent side effects of pegylated liposomal doxorubicin monotherapy in women with metastatic breast cancer: a systematic review of clinical trials" 24 : 189-193, 2017
3 Liu E, "Sustained ERK activation-mediated proliferation inhibition of farrerol on human gastric carcinoma cell line by G0/G1-phase cell-cycle arrest" 25 : 490-499, 2016
4 Qiu J, "Subinhibitory concentrations of farrerol reduce α-toxin expression in Staphylococcus aureus" 315 : 129-133, 2011
5 Longman AJ, "Side effects burden in women with breast cancer" 4 : 274-280, 1996
6 Lu R, "Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells" 179 : 297-304, 1999
7 정규원, "Prediction of Cancer Incidence and Mortality in Korea, 2018" 대한암학회 50 (50): 317-323, 2018
8 Xia Z, "Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis" 270 : 1326-1331, 1995
9 Wang W, "Natural product ginsenoside 25-OCH3-PPD inhibits breast cancer growth and metastasis through down-regulating MDM2" 7 : 2012
10 Wada T, "Mitogen-activated protein kinases in apoptosis regulation" 23 : 2838-2849, 2004
1 Boise LH, "a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death" 74 : 597-608, 1993
2 Ansari L, "The most prevalent side effects of pegylated liposomal doxorubicin monotherapy in women with metastatic breast cancer: a systematic review of clinical trials" 24 : 189-193, 2017
3 Liu E, "Sustained ERK activation-mediated proliferation inhibition of farrerol on human gastric carcinoma cell line by G0/G1-phase cell-cycle arrest" 25 : 490-499, 2016
4 Qiu J, "Subinhibitory concentrations of farrerol reduce α-toxin expression in Staphylococcus aureus" 315 : 129-133, 2011
5 Longman AJ, "Side effects burden in women with breast cancer" 4 : 274-280, 1996
6 Lu R, "Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells" 179 : 297-304, 1999
7 정규원, "Prediction of Cancer Incidence and Mortality in Korea, 2018" 대한암학회 50 (50): 317-323, 2018
8 Xia Z, "Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis" 270 : 1326-1331, 1995
9 Wang W, "Natural product ginsenoside 25-OCH3-PPD inhibits breast cancer growth and metastasis through down-regulating MDM2" 7 : 2012
10 Wada T, "Mitogen-activated protein kinases in apoptosis regulation" 23 : 2838-2849, 2004
11 Li Qy, "Involvement of estrogen receptor-â in farrerol inhibition of rat thoracic aorta vascular smooth muscle cell proliferation" 32 : 433-440, 2011
12 Kim MY, "Induction of apoptosis by Citrus unshiu Peel in human breast cancer MCF-7 cells: Involvement of ROSdependent activation of AMPK" 41 : 713-721, 2018
13 Dai F, "Farrerol inhibited angiogenesis through Akt/mTOR, Erk and Jak2/Stat3 signal pathway" 23 : 686-693, 2016
14 Ci X, "Different effects of farrerol on an OVA-induced allergic asthma and LPS-induced acute lung injury" 7 : 2012
15 Peng YY, Liu FH, Ye JN, "Determination of Bioactive Flavonoids in Rhododendron Dauricum L. by Capillary Electrophoresis with Electrochemical Detection" 60 : 597-602, 2004
16 Verma SP, "Curcumin and genistein, plant natural products, show synergistic inhibitory effects on the growth of human breast cancer MCF-7 cells induced by estrogenic pesticides" 233 : 692-696, 1997
17 Ledford H, "Complex synthesis yields breast-cancer therapy" 468 : 608-609, 2010
18 Cao Y, "Chromatographic and electrophoretic methods for pharmaceutically active compounds in Rhododendron dauricum" 812 : 231-240, 2004
19 Elmore S, "Apoptosis: a review of programmed cell death" 35 : 495-516, 2007
20 Liu E, "Apoptosis induced by farrerol in human gastric cancer SGC-7901 cells through the mitochondrial-mediated pathway" 24 : 365-372, 2015
21 Woyengo T, "Anticancer effects of phytosterols" 63 : 813-820, 2009
22 Borsello T, "A peptide inhibitor of c-Jun Nterminal kinase protects against excitotoxicity and cerebral ischemia" 9 : 1180-1186, 2003
23 Wu C, "A case-control study of risk factors for fibrocystic breast conditions: Shanghai Nutrition and Breast Disease Study, China, 1995–2000" 160 : 945-960, 2004